144 related articles for article (PubMed ID: 10400222)
1. Anti-analgesia and reduced antinociception from supraspinally administered beta-endorphin in stressed rats: dependence on spinal cholecystokinin via cholecystokinin B receptors.
Hawranko AA; Serafini M; Smith DJ
Neurosci Lett; 1999 May; 267(2):101-4. PubMed ID: 10400222
[TBL] [Abstract][Full Text] [Related]
2. Stress reduces morphine's antinociceptive potency: dependence upon spinal cholecystokinin processes.
Hawranko AA; Smith DJ
Brain Res; 1999 Apr; 824(2):251-7. PubMed ID: 10196456
[TBL] [Abstract][Full Text] [Related]
3. Participation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mustard oil.
Urban MO; Jiang MC; Gebhart GF
Brain Res; 1996 Oct; 737(1-2):83-91. PubMed ID: 8930354
[TBL] [Abstract][Full Text] [Related]
4. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
Lavigne GJ; Millington WR; Mueller GP
Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1086-92. PubMed ID: 1545380
[TBL] [Abstract][Full Text] [Related]
7. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
Friedrich AE; Gebhart GF
J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
[TBL] [Abstract][Full Text] [Related]
8. Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
Urban MO; Smith DJ; Gebhart GF
J Pharmacol Exp Ther; 1996 Jul; 278(1):90-6. PubMed ID: 8764339
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
Lu L; Zhang B; Liu Z; Zhang Z
Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
[TBL] [Abstract][Full Text] [Related]
10. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
Zhou Y; Sun YH; Zhang ZW; Han JS
Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
[TBL] [Abstract][Full Text] [Related]
11. Role of cholecystokinin receptors in induction of antinociception in hot-plate test.
Rezayat M; Rahnavard A; Zarrindast MR
Pharmacol Toxicol; 2000 Aug; 87(2):58-62. PubMed ID: 10989941
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
Derrien M; Noble F; Maldonado R; Roques BP
Neurosci Lett; 1993 Oct; 160(2):193-6. PubMed ID: 8247353
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
Sullivan AF; Hewett K; Dickenson AH
Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
[TBL] [Abstract][Full Text] [Related]
14. Interactions between antinociception induced by cholecystokinin antagonists and GABA agonists in the tail-flick test.
Zarrindast MR; Rezayat M; Ghanipoor N; Parvini S
Pharmacol Toxicol; 1998 Oct; 83(4):143-8. PubMed ID: 9820874
[TBL] [Abstract][Full Text] [Related]
15. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationship study on some nonpeptidal cholecystokinin antagonists.
Sinha J; Kurup A; Paleti A; Gupta SP
Bioorg Med Chem; 1999 Jun; 7(6):1127-30. PubMed ID: 10428383
[TBL] [Abstract][Full Text] [Related]
17. Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat.
Tseng LF; Tsai JH; Collins KA; Portoghese PS
Eur J Pharmacol; 1995 Apr; 277(2-3):251-6. PubMed ID: 7493616
[TBL] [Abstract][Full Text] [Related]
18. Involvement of supraspinal and spinal CCK receptors in the modulation of antinociception induced by cold water swimming stress in the mouse.
Suh HW; Song DK; Kwon SH; Kim KW; Min BH; Kim YH
Neuropeptides; 1996 Aug; 30(4):379-84. PubMed ID: 8914865
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.
Lu L; Huang M; Liu Z; Ma L
Neuroreport; 2000 Mar; 11(4):829-32. PubMed ID: 10757528
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
Zavros Y; Shulkes A
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]